EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis | ALK

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

Link
https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-m…
Created date
Nasdaq ID
3265184
Last updated: 31.03.2026